ADVOCATING FOR A NEW ERA OF BREAST CANCER CARE
We are a small and nimble organization that focuses on where we can make the greatest impact. We are not working on traditional care. We can make the greatest impact by accelerating and bringing the scientific revolution to save every life possible.
In order to effect lasting change, the Pink Eraser Project® is committed to joining the effort on the pressing need for legislation that meets the scientific opportunities of this era on state, national, and international levels. We want policy to bring state-of-the-art detection and treatments to all women, not just a select few. We were among the first to shoutout to the rooftops about the promise of therapeutic vaccines. We will continue to be at the vanguard of the change that needs to happen for breast cancer to be erased.
Among insurers, legislators, and pharmaceutical companies, outdated attitudes and expensive treatments still dominate. Approximately 2-5% of breast cancer research funding is allocated to stage 4 breast cancer, and rarely is this research curative.¹ Personalized treatments, which offer hope for a cure, are rarely covered by health plans. Patients are therefore not being given the best chance of survival, and this is unacceptable. We are looking to the future because the science is there.
At the Pink Eraser Project®, our advocacy seeks to educate on and facilitate detection, promote access to new therapies, and stop pretending that it is morally appropriate to use yesterday’s science when today’s offers a new lease of life. Furthermore, our immune system needs to be cared for through boosters, lifestyle, and exercise. Like an invasive weed, pruning leaves does nothing. It has to be pulled out from the root.
The Breast Cancer Bill (H.B. 371)
Michele’s advocacy brought together physicians, survivors, and politicians. This resulted in the signing of H.B. 371, coined the Breast Cancer Bill, into law in Ohio in 2022, requiring coverage from private insurance and Medicaid for mammograms, while also mandating additional screenings for women with dense breasts.
The BEST Act (H.B. 271)
We are pushing to pass H.B. 271, the Breast Examination and Screening Transformation Act, which builds on the success of H.B. 371 to eliminate cost-sharing on essential supplementary screenings. Download our Pink Paper on the financial toxicity of breast cancer and why we need bills like H.B. 271. Our approach is evidence and research-based.
Championing National Change on Capitol Hill
Early Detection Saves Lives & Money
We firmly believe that this is a national movement, already passing in numerous state legislatures, and we have inspired similar Federal bills, like the Find It Early Act, in D.C. Why should we stand by outdated notions of care? America can set the global standard for early detection and treatment and ensure no woman faces metastatic stage-4 cancer.
Access to Screenings
We know that breast cancer is close to 100% curable if caught early.² But that is the luck of the draw. Only in a few states can your radiologist provide supplemental screening at no cost, and in over 15 states, there are no rights to this screening.³ Every woman in America deserves equitable access to life-saving additional screenings.
Gene Therapy, Immunotherapy, Therapeutic Vaccines, Holistic Care
We are thinking bigger. The gap between what is offered and what should be offered is the difference between life and death. It is a moral imperative to revisit international, national, and state laws and ask how we can close that gap. Many stage 4 women are still being treated as if it were 50 years ago. This is not working for the more than 42,000 women who die each year.⁴ Lawmakers should increase and promote equitable access to novel treatments and to the best standard of care.
Breast Cancer Awareness Month
Will you pitch in? Our team relies on grassroots contributions to do our work which includes advancing breast cancer policy, access, and care through science, legislative action, and education.